Sfoglia per Autore
Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases
1998-01-01 DI BONA, D; Montalto, G; Clemenza, L; Bascone, F; Accardo, P; Bellavia, D; Craxì, A; Brai, M
Soluble complement receptor type 1 (sCR1) in chronic liver diseases: Serum levels at different stages of liver diseases
1998-01-01 Di Bona, D.; Montalto, G.; Clemenza, L.; Bascone, F.; Accardo, P.; Bellavia, D.; Craxi, A.; Brai, M.
Negative regulation of CD95 ligand gene expression by vitamin D3in T lymphocytes
2002-01-01 Cippitelli, M.; Fionda, C.; Di Bona, D.; Di Rosa, F.; Lupo, A.; Piccoli, M.; Frati, L.; Santoni, A.
Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes
2002-01-01 Cippitelli, M; Fionda, C; DI BONA, D; DI ROSA, F; Lupo, A; Piccoli, M; Frati, L; Santoni, A
Interferon-alpha for HBeAg-positive chronic hepatitis B
2003-01-01 Craxì, A; DI BONA, D; Cammà, C
Interferon-alpha for HBeAg-positive chronic hepatitis B
2003-01-01 Craxì, Antonio; Di Bona, Danilo; Cammà, Calogero
When and how to treat acute hepatitis C?
2003-01-01 Licata, A; DI BONA, D; Schepis, F; Shahied, L; Craxí, A; Cammà, C
The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms
2003-01-01 Cippitelli, M; Fionda, C; DI BONA, D; Lupo, A; Piccoli, M; Frati, L; Santoni, A
When and how to treat acute hepatitis C?
2003-01-01 Licata, A.; Di Bona, D.; Schepis, F.; Shahied, L.; Craxi, A.; Camma, C.
Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial
2004-01-01 Bruno, S; Cammà, C; DI MARCO, V; Rumi, M; Vinci, M; Camozzi, M; Rebucci, C; DI BONA, D; D, ; Colombo, M; Craxì, A; Mondelli, Mu; Pinzello, G
Quality-related variables at hepatological websites
2004-01-01 Fraquelli, M; Conte, D; Cammà, C; Casazza, G; DI BONA, D; Rebulla, P; Prati, D
Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis
2004-01-01 Fiorica, F.; Di Bona, D.; Schepis, F.; Licata, A.; Shahied, L.; Venturi, A.; Falchi, A. M.; Craxi, A.; Camma, C.
The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach
2004-01-01 Cammà, C; DI BONA, D; Craxì, A
Quality-related variables at hepatological websites
2004-01-01 Fraquelli, M.; Conte, D.; Camma, C.; Casazza, G.; Di Bona, D.; Rebulla, P.; Prati, D.
Effect of Peginterferon Alfa-2a on Liver Histology in Chronic Hepatitis C: A Meta-analysis of Individual Patient Data
2004-01-01 Camma, C.; Di Bona, D.; Schepis, F.; Heathcote, J.; Zeuzem, S.; Pockros, P. J.; Marceliln, P.; Balart, L.; Alberti, A.; Craxi, A.
The impact of antiviral treatments on the course of chronic hepatitis C: An evidence-based approach
2004-01-01 Camma, C.; Di Bona, D.; Craxi, A.
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis
2004-01-01 Fiorica, F; DI BONA, D; Schepis, F; Licata, A; Shahied, L; Venturi, A; Falchi, Am; Craxì, A; Cammà, C
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data
2004-01-01 Cammà, C; DI BONA, D; Schepis, F; Heathcote, Ej; Zeuzem, S; Pockros, Pj; Marcellin, ; P, ; Balart, L; Alberti, A; Craxì, A
Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: A randomized controlled trial
2004-01-01 Bruno, S.; Camma, C.; Di Marco, V.; Rumi, M.; Vinci, M.; Camozzi, M.; Rebucci, C.; Di Bona, D.; Colombo, M.; Craxi, A.; Mondelli, M. U.; Pinzello, G.
Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center
2005-01-01 Licata, A; Di Marco, V; Parisi, P; Latteri, F; Nebbia, M E; Cabibbo, G; Di Bona, D; Prinzi, G; Li Petri, S; Sandonato, L; Latteri, M A; Craxì, A; Cammà, C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases | 1-gen-1998 | DI BONA, D; Montalto, G; Clemenza, L; Bascone, F; Accardo, P; Bellavia, D; Craxì, A; Brai, M | |
| Soluble complement receptor type 1 (sCR1) in chronic liver diseases: Serum levels at different stages of liver diseases | 1-gen-1998 | Di Bona, D.; Montalto, G.; Clemenza, L.; Bascone, F.; Accardo, P.; Bellavia, D.; Craxi, A.; Brai, M. | |
| Negative regulation of CD95 ligand gene expression by vitamin D3in T lymphocytes | 1-gen-2002 | Cippitelli, M.; Fionda, C.; Di Bona, D.; Di Rosa, F.; Lupo, A.; Piccoli, M.; Frati, L.; Santoni, A. | |
| Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes | 1-gen-2002 | Cippitelli, M; Fionda, C; DI BONA, D; DI ROSA, F; Lupo, A; Piccoli, M; Frati, L; Santoni, A | |
| Interferon-alpha for HBeAg-positive chronic hepatitis B | 1-gen-2003 | Craxì, A; DI BONA, D; Cammà, C | |
| Interferon-alpha for HBeAg-positive chronic hepatitis B | 1-gen-2003 | Craxì, Antonio; Di Bona, Danilo; Cammà, Calogero | |
| When and how to treat acute hepatitis C? | 1-gen-2003 | Licata, A; DI BONA, D; Schepis, F; Shahied, L; Craxí, A; Cammà, C | |
| The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms | 1-gen-2003 | Cippitelli, M; Fionda, C; DI BONA, D; Lupo, A; Piccoli, M; Frati, L; Santoni, A | |
| When and how to treat acute hepatitis C? | 1-gen-2003 | Licata, A.; Di Bona, D.; Schepis, F.; Shahied, L.; Craxi, A.; Camma, C. | |
| Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial | 1-gen-2004 | Bruno, S; Cammà, C; DI MARCO, V; Rumi, M; Vinci, M; Camozzi, M; Rebucci, C; DI BONA, D; D, ; Colombo, M; Craxì, A; Mondelli, Mu; Pinzello, G | |
| Quality-related variables at hepatological websites | 1-gen-2004 | Fraquelli, M; Conte, D; Cammà, C; Casazza, G; DI BONA, D; Rebulla, P; Prati, D | |
| Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis | 1-gen-2004 | Fiorica, F.; Di Bona, D.; Schepis, F.; Licata, A.; Shahied, L.; Venturi, A.; Falchi, A. M.; Craxi, A.; Camma, C. | |
| The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach | 1-gen-2004 | Cammà, C; DI BONA, D; Craxì, A | |
| Quality-related variables at hepatological websites | 1-gen-2004 | Fraquelli, M.; Conte, D.; Camma, C.; Casazza, G.; Di Bona, D.; Rebulla, P.; Prati, D. | |
| Effect of Peginterferon Alfa-2a on Liver Histology in Chronic Hepatitis C: A Meta-analysis of Individual Patient Data | 1-gen-2004 | Camma, C.; Di Bona, D.; Schepis, F.; Heathcote, J.; Zeuzem, S.; Pockros, P. J.; Marceliln, P.; Balart, L.; Alberti, A.; Craxi, A. | |
| The impact of antiviral treatments on the course of chronic hepatitis C: An evidence-based approach | 1-gen-2004 | Camma, C.; Di Bona, D.; Craxi, A. | |
| Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis | 1-gen-2004 | Fiorica, F; DI BONA, D; Schepis, F; Licata, A; Shahied, L; Venturi, A; Falchi, Am; Craxì, A; Cammà, C | |
| Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data | 1-gen-2004 | Cammà, C; DI BONA, D; Schepis, F; Heathcote, Ej; Zeuzem, S; Pockros, Pj; Marcellin, ; P, ; Balart, L; Alberti, A; Craxì, A | |
| Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: A randomized controlled trial | 1-gen-2004 | Bruno, S.; Camma, C.; Di Marco, V.; Rumi, M.; Vinci, M.; Camozzi, M.; Rebucci, C.; Di Bona, D.; Colombo, M.; Craxi, A.; Mondelli, M. U.; Pinzello, G. | |
| Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center | 1-gen-2005 | Licata, A; Di Marco, V; Parisi, P; Latteri, F; Nebbia, M E; Cabibbo, G; Di Bona, D; Prinzi, G; Li Petri, S; Sandonato, L; Latteri, M A; Craxì, A; Cammà, C |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile